Background and Objectives: Insulinoma is a rare tumor of the Langerhans islets of the pancreas. It produces insulin and causes severe hypoglycemia with neuroglycopenic symptoms. The incidence is low, at about 1-2 per 1 million inhabitants per year. The diagnosis is based on the presence of Whipple's triad and the result of a fasting test. Surgery is the treatment of choice. Objectives: A retrospective observational study of patients operated on for insulinoma in our hospital focused on the diagnosis, the type of surgery, and complications. Materials and Methods: We retrospectively reviewed patients operated on due to insulinoma. There were 116 surgeries between 2000 and 2022. There were 79 females and 37 males in this group. A fasting test and a CT examination were performed on all the patients. Results: The average duration of the fasting test was 18 h. Insulinoma was found in the body and tail of the pancreas in more than half of the patients. Enucleation was the most frequent type of surgery. Complications that were Clavien Dindo grade III or more occurred in 18% of the patients. The most frequent complications were abscesses and pancreatic fistula. Five patients had malignant insulinoma. Conclusions: Surgery is the treatment of choice in the case of insulinomas. The enucleation of the tumor is a sufficient treatment for benign insulinomas, which are not in contact with the main pancreatic duct. Due to the low incidence of the condition, the centralization of patients is recommended.

1st Department of Surgery General University Hospital U nemocnice 2 12000 Prague Czech Republic

1st Medical Faculty Charles University Katerinska 32 12000 Prague Czech Republic

3rd Department of Inner Medicine General University Hospital U nemocnice 2 12000 Prague Czech Republic

Zobrazit více v PubMed

Maggio I., Mollica V., Brighi N., Lamberti G., Manuzzi L., Ricci A.D., Campana D. The functioning side of the pancreas: A review on insulinomas. J. Endocrinol. Investig. 2020;43:139–148. doi: 10.1007/s40618-019-01091-w. PubMed DOI

Peltola E., Hannula P., Huhtala H., Metso S., Kiviniemi U., Vornanen M., Sand J., Laukkarinen J., Tiikkainen M., Schalin-Jäntti C., et al. Characteristics and Outcomes of 79 Patients with an Insulinoma: A Nationwide Retrospective Study in Finland. Int. J. Endocrinol. 2018;2018:2059481. doi: 10.1155/2018/2059481. PubMed DOI PMC

Wei J., Liu X., Wu J., Xu W., Gao W., Jiang K., Zhang Z., Miao Y. Diagnosis and surgical management of insulinomas in 33 consecutive patients at a single institution. Langenbeck’s Arch. Surg. 2016;401:1019–1025. doi: 10.1007/s00423-016-1496-y. PubMed DOI

Jyotsna V.P., Pal S., Kandasamy D., Gamanagatti S., Garg P., Raizada N., Sahni P., Bal C., Tandon N., Ammini A. Evolving management of insulinoma: Experience at a tertiary care centre. Indian J. Med. Res. 2016;144:771–777. doi: 10.4103/ijmr.IJMR_1477_14. PubMed DOI PMC

Durczyński A., Hogendorf P., Szymański D., Izdebski W., Kaczka A., Durko Ł., Strzelczyk J. Insulinoma—rare, but important clinical problem. Analysis of a Series of 530 Patients Who Underwent Surgical Treatment for the Pancreatic Tumor. Pol. J. Surg. 2015;86:505–510. doi: 10.2478/pjs-2014-0090. PubMed DOI

Gut P., Waligórska-Stachura J., Czarnywojtek A., Sawicka-Gutaj N., Bączyk M., Ziemnicka K., Fischbach J., Woliński K., Kaznowski J., Wrotkowska E., et al. Management of the hormonal syndrome of neuroendocrine tumors. Arch. Med. Sci. 2017;13:515–524. doi: 10.5114/aoms.2016.60311. PubMed DOI PMC

Skrha J., Sváb J., Krusina L., Dusková J., Hilgertová J., Keil R. Diagnostics and treatment of organic hyperinsulinism--experience in 105 cases. Cas. Lek. Cesk. 2009;148:389–394. PubMed

Kalra P., Anakal M.G., Dharmalingam M., Indushekhar S., Rao V., Kumar K.P. Insulinoma case series: Experience of a tertiary care center. Indian J. Endocrinol. Metab. 2014;18:858–862. doi: 10.4103/2230-8210.141385. PubMed DOI PMC

Bartsch D.K., Albers M., Knoop R., Kann P.H., Fendrich V., Waldmann J. Enucleation and Limited Pancreatic Resection Provide Long-Term Cure for Insulinoma in Multiple Endocrine Neoplasia Type. Neuroendocrinology. 2013;98:290–298. doi: 10.1159/000357779. PubMed DOI

Antwi K., Nicolas G., Fani M., Heye T., Pattou F., Grossman A., Chanson P., Reubi J.C., Perren A., Gloor B., et al. 68Ga-Exendin-4 PET/CT Detects Insulinomas in Patients with Endogenous Hyperinsulinemic Hypoglycemia in MEN-1. J. Clin. Endocrinol. Metab. 2019;104:5843–5852. doi: 10.1210/jc.2018-02754. PubMed DOI

Burghardt L., Meier J.J., Uhl W., Kahle-Stefan M., Schmidt W.E., Nauck M.A. Importance of localization of insulinomas: A systematic analysis. J. Hepato-Biliary-Pancreatic Sci. 2019;26:383–392. doi: 10.1002/jhbp.642. PubMed DOI

Doi R. Determinants of surgical resection for pancreatic neuroendocrine tumors. J. Hepato-Biliary-Pancreatic Sci. 2015;22:610–617. doi: 10.1002/jhbp.224. PubMed DOI

Constantinescu D.P., Constantinescu M.I., Ciocan R.-A., Chiorescu S., Pop M.G., Pintea D.S., Muntean V. Near infrared light examination as part of the management of sporadic pancreatic head insulinoma: Case report. Int. J. Surg. Case Rep. 2019;64:35–40. doi: 10.1016/j.ijscr.2019.09.024. PubMed DOI PMC

Fendrich V., Bartsch D.K. Surgical Therapy of Sporadic Pancreatic Neuroendocrine Neoplasias G1/G2. Visc. Med. 2017;33:344–350. doi: 10.1159/000456630. PubMed DOI PMC

Crippa S., Zerbi A., Boninsegna L., Capitanio V., Partelli S., Balzano G., Pederzoli P., Di Carlo V., Falconi M. Surgical management of insulinomas: Short- and long-term outcomes after enucleations and pancreatic resections. Arch. Surg. 2012;147:261–266. doi: 10.1001/archsurg.2011.1843. PubMed DOI

Mehrabi A., Fischer L., Hafezi M., Dirlewanger A., Grenacher L., Diener M.K., Fonouni H., Golriz M., Garoussi C., Fard N., et al. A Systematic Review of Localization, Surgical Treatment Options, and Outcome of Insulinoma. Pancreas. 2014;43:675–686. doi: 10.1097/MPA.0000000000000110. PubMed DOI

[(accessed on 18 July 2023)]. Available online: https://www.enets.org/guidelines.html.

Hackert T., Hinz U., Fritz S., Strobel O., Schneider L., Hartwig W., Büchler M.W., Werner J. Enucleation in pancreatic surgery: Indications, technique, and outcome compared to standard pancreatic resections. Langenbeck’s Arch. Surg. 2011;396:1197–1203. doi: 10.1007/s00423-011-0801-z. PubMed DOI

Câmara-De-Souza A., Toyoshima M., Giannella M., Freire D., Camacho C., Lourenço D., Rocha M., Bacchella T., Jureidini R., Machado M., et al. Insulinoma: A retrospective study analyzing the differences between benign and malignant tumors. Pancreatology. 2018;18:298–303. doi: 10.1016/j.pan.2018.01.009. PubMed DOI

Yu J., Ping F., Zhang H., Li W., Yuan T., Fu Y., Feng K., Xia W., Xu L., Li Y. Clinical Management of Malignant Insulinoma: A single Institution’s experience over three decades. BMC Endocr. Disord. 2018;18:92. doi: 10.1186/s12902-018-0321-8. PubMed DOI PMC